Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer
Conditions
Invasive Breast Cancer
Conditions: official terms
Breast Neoplasms
Study Type
Interventional
Study Phase
Phase 4
Study Design
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Intervention
Name: MRI
Type: Radiation
Overall Status
Recruiting
Summary
This study examines the additional benefits of magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features.
Detailed Description
Dedicated Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- Patients with invasive ductal carcinoma

- Patients undergoing DCE-MRI scan which are assessed according to BI-RADS lexicon

- Breast cancer patients with pathological diagnosed invasive ductal carcinoma with hormonal receptor (ER, PR and HER-2) response

- Patients who have signed on informed consent form Patients will undergo MRI imaging and the physicians will practice according to practice guidelines.

Exclusion Criteria:

- Patients under 18 years old or during pregnancy

- Patients with MRI's contraindications e.g. patients with cardiac pacemaker or are allergic to MRI contrast agent Patients with unstable clinical abnormality and might get unexpected clinical treatment
Location
Faculty of Medicine Siriraj Hospital
Bangkoknoi, Bangkok, Thailand
Status: Recruiting
Contact: Dr.Pornpim Korpraphong, Assist.Prof. - 662-4197000 - pfuang@yahoo.com
Start Date
February 2011
Completion Date
December 2013
Sponsors
Mahidol University
Source
Mahidol University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page